MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

Date of Original Release: November 15, 2018
Date Credit Expires: November 15, 2020

Learning Objectives

• Discuss new therapies to manage Parkinson’s symptoms.
• Summarize what therapies are in clinical trials to slow or stop Parkinson’s progression.
• Describe progress toward tests to diagnose and track Parkinson’s.
• Explain anticipated progress in the Parkinson’s field in 2019.  

Target Audience

This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Oakstone Publishing, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.

Faculty

Soania Mathur, MD (Moderator)
Retired family physician
Co-Chair, MJFF Patient Council
Nothing to disclose

Andrew Siderowf, MD
Director, Parkinson's Disease and Movement Disorders Center
Chief, Movement Disorders Division, 
University of Pennsylvania
Co-Principal Investigator, Parkinson’s Progression Markers Initiative
Advisory Roles: Biogen, Merck, Voyager, Wave, Prilenia

Todd Sherer, PhD
CEO
The Michael J. Fox Foundation
Wife works at Pfizer.